Remedium Lifecare Q2 Profit Jumps 92% to ₹38.62 Cr
Remedium Lifecare reports stellar Q2 results with profit nearly doubling to ₹38.62 crore. Revenue surges 22% driven by strong pharmaceutical exports and domestic growth.
Category : Search result: pharma fundraising
QIP Warning: 4 Stocks That Fell After Peak Valuations
Indian companies raised ₹50,106 crore via QIPs in H1 2025. Discover why stocks like PG Electroplast and Amber Enterprises fell up to 47% after fundraising at peak valuations. Learn the investor lesson.
European Pharma Stocks Rebound from AI Shift
European weight-loss drug makers surge as investors rotate capital from expensive AI stocks into healthcare. Zealand Pharma leads with a 20% weekly jump. Explore the market dynamics.
Purdue Pharma Wins Bankruptcy Approval in Opioid Case
Purdue Pharma receives court approval for $7.4 billion opioid settlement after Supreme Court intervention. Sackler family to pay $6.5 billion over 15 years in landmark case.
Purdue Pharma $7B Opioid Settlement Gets Court Nod
Federal judge approves Purdue Pharma's bankruptcy plan requiring Sackler family to pay $7 billion and surrender company ownership. Thousands of opioid victims to receive compensation in historic settlement.
Lincoln Pharma Aims for Rs 1000 Crore Revenue
Lincoln Pharmaceuticals Ltd announces ambitious plan to achieve Rs 1000 crore revenue within three years through strategic expansion and new product launches. Read more about their growth strategy.
OneSource Pharma Raises FY28 Revenue Target to $500M
OneSource Pharma hikes FY28 revenue guidance to over $500 million, plans $100M expansion for weight-loss drugs like semaglutide. CEO reveals accelerated growth strategy.
Gujarat Pharma Factory Blast: 2 Dead, 20 Injured
Tragic boiler explosion at pharmaceutical factory in Gujarat's Bharuch district claims 2 lives, leaves 20 injured. Massive fire brought under control by emergency teams.
Adani Enterprises ₹25,000 Crore Rights Issue Approved
Adani Enterprises board approves a massive ₹25,000 crore rights issue. Get all details on share price, record date, payment schedule, and how it impacts investors.
India's Drug Regulator Tightens Pharma Quality Control
India's DCGI orders nationwide inspections of small pharma units as WHO flags toxic cough syrups. MSMEs struggle to meet new Schedule M compliance deadline of January 2026.
Bartronics India Board to Consider ₹300 Crore Fundraise
Bartronics India's board will meet on Nov 14, 2025, to consider fundraising up to ₹300 crore and approve Q2 results. This comes after a sharp 45% YoY profit decline in Q1. Discover the stock's performance and investment outlook.
Indian Pharma Units Face Closure Over GMP Non-Compliance
DCGI directs state authorities to enforce strict GMP compliance by December 31, 2025. Delhi, Himachal Pradesh, Uttarakhand already taking action against non-compliant manufacturers.
DCGI Orders Global Pharma Standards Implementation by Jan 2026
India's drug regulator DCGI mandates global manufacturing standards for all pharma companies by January 2026. State regulators ordered to begin inspections immediately. Read about the strict compliance requirements.
Sun Pharma: US Tariff Clarity & Q2 FY26 Outlook
Sun Pharma investors await Q2 FY26 results with cautious optimism as US tariff clarity emerges. Discover how import duties and market dynamics could impact India's pharmaceutical giant.
Muthoot Finance Board Meeting: Q2 Results & NCD Plans
Muthoot Finance announces crucial board meeting on October 18 to declare Q2 FY2025 financial results and approve fundraising through NCDs. Get key details about the gold loan giant's strategic moves.
Indian Pharma Soars with Record US Generic Drug Profits
Indian pharmaceutical companies are reporting exceptional earnings driven by US generic drug sales, leading to major fundraising initiatives for expansion into medtech and wellness sectors.
AstraZeneca Q3 Profit Jumps 77% to $2.53 Billion
British-Swedish pharma giant AstraZeneca reports blockbuster Q3 results with profits surging 77% to $2.53 billion, driven by robust cancer drug sales and strategic US market expansion.
Piramal Pharma Bets on US Biopharma Funding Revival
Piramal Pharma anticipates significant growth as US biopharma funding shows recovery signs, with CDMO business poised for major expansion.
Man funds wedding selling suit ads, raises ₹8.86 lakh
A resourceful Indian man turned down big corporate deals and instead sold advertising space on his wedding suit, raising an impressive ₹8.86 lakh through small businesses and individual sponsors.
Solara Pharma Q2 Loss: ₹10 Crore Amid Challenges
Solara Active Pharma Sciences faces challenging quarter with ₹10 crore net loss despite revenue growth. Discover the operational challenges and management's recovery strategy.
Sun Pharma Q2 Profit Rises 2.5% to ₹3,118 Crore
India's pharmaceutical giant Sun Pharma reports steady Q2 growth with 9% revenue increase while navigating US market challenges. Key insights from their latest earnings report.
₹250 Cr Fundraising Approved: Sub-₹100 Stock in Spotlight
A prominent company's board has approved raising ₹250 crore through various instruments, putting this affordable stock under ₹100 in the spotlight for investors seeking high-growth opportunities.
Adani Energy Solutions Board Meets for Fundraising
Adani Energy Solutions board to meet Thursday to consider fundraising options, potentially impacting share price. Key details investors need to know.
Navin Fluorine Shares Surge 22% in 3 Sessions
Discover why Navin Fluorine International shares skyrocketed 22% in just three trading sessions. Expert analysis reveals the key drivers behind this chemical sector powerhouse's impressive rally and what investors should watch next.
Q2 Results Today: Sun Pharma, Grasim, Britannia Earnings
Market eyes Wednesday's Q2 earnings bonanza as pharma giant Sun Pharma, Grasim Industries, and FMCG major Britannia declare results. Get complete analysis and investor expectations.
Adani Enterprises to raise ₹25,000 crore via rights issue
Adani Enterprises board greenlights massive ₹25,000 crore fundraising through rights issue, signaling strong growth ambitions and market confidence in the conglomerate's expansion plans.
Penny Stock Under ₹2 Sets Board Meeting for Q2 Results
Discover how this sub-₹2 penny stock is gearing up for its Q2 FY2025 results announcement and revised fundraising strategy in an upcoming board meeting that could impact investors.
3 Hot Stocks: Grasim, Aurobindo Pharma, City Union Bank
Religare Broking's Ajit Mishra reveals 3 promising stocks for short-term gains. Discover technical analysis and price targets for Grasim, Aurobindo Pharma, and City Union Bank in this exclusive market insight.
Vodafone Idea Shares Surge 10% in Market Rally
Vodafone Idea's stock witnessed a massive 10% surge as fundraising hopes and positive market sentiment ignited investor interest. Discover the key factors behind this telecom stock's impressive performance.
Hot Stocks: Oil India, Aurobindo Pharma, Latent View Analysis
Get expert stock market insights from Jigar Patel of Anand Rathi as he reveals why Oil India, Aurobindo Pharma, and Latent View Analytics present compelling short-term opportunities for Indian investors.
Page 3 of 4